Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Sarepta Therapeutics Inc. logo

Sarepta Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

113.33
 
USD
  
-10.13
  
(-8.21%)
Optionable: Yes  Market Cap: 12,205 M  90-day average vol: 900,991

Previous close: 123.46  Open: 119.02  Bid: 113.4  Ask: 117.5
52 week range    
55.25   
   146.68
Peers   
GILD / 
NVAX / 
RNA / 
PTCT / 
ALNY / 
BCRX / 
Last updated: Wednesday 29th May 2024
40
MarketXLS Rank
40
Value
38
Technical
42
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ALNY

17 B-19.3148.65

BCRX

3 B-12.216.38

GILD

0.044486 B11.763.76

INSM

3 B-5.822.51

NVAX

7 B-6.394.8

PTCT

3 B-6.243.17

RNA

1 B-7.116.82
Financials

SRPT Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Amortization of intangibles29000.01 M900000.0800000.0700000.0700000.0714000.02 M
Basic EPS from continuing operations-3.39-5.49-0.86-5.46-9.71-7.11-5.15-8.03-5.8
Basic EPS total-3.39-5.49-0.86-5.46-9.71-7.11-5.15-8.03-5.8
Basic weighted shares outstanding40 M42 M49 M59 M66 M74 M78 M81 M88 M92 M
Cost of sales221 M-101000.0-36 M-34 M-67 M-63 M-107 M-140 M-150 M
Depreciation3 M5 M5 M6 M10 M23 M25 M37 M40 M43 M
Depreciation unreconciled29000.01 M900000.0800000.0700000.0700000.0714000.02 M
DepreciationAndAmortization3 M5 M29000.01 M900000.0800000.0700000.0700000.0714000.02 M
Diluted EPS total-3.39-5.2-5.49-0.86-5.46-9.71-7.11-5.15-8.03-5.8
Diluted normalized net income/share-8.03-5.8
Diluted weighted shares outstanding40 M42 M49 M59 M74 M78 M81 M88 M92 M
GeneralAndAdministrativeExpense49 M75 M84 M123 M208 M285 M318 M283 M451 M482 M
Gross operating profit10 M1 M6 M190 M335 M447 M603 M809 M1,073 M1,394 M
Income before tax-136 M-220 M-267 M-49 M-363 M-714 M-553 M-419 M-690 M-520 M
Income restructuring and M&A14000.05 M3 M-2 M
Income taxes2 M-692000.01 M1 M-168000.014 M16 M
Interest income154000.0507000.02 M7 M7 M3 M354000.016 M36 M
InterestExpenseNonOperating100000.02 M6 M34 M31 M60 M64 M53 M22 M
MinorityInterests248 M190 M337 M
MiscOtherSpecialCharges-2 M154000.0-535000.0123 M-19 M-8 M95 M130 M-65 M-154 M
Net income from total operations-136 M-220 M-267 M-51 M-362 M-715 M-554 M-419 M-703 M-536 M
NetIncomeCommonStockholders-136 M-220 M-267 M21 M7 M-582 M-427 M-419 M-703 M-536 M
NetIncomeContinuousOperations-136 M-220 M-267 M-51 M-362 M-715 M-554 M-419 M-703 M-536 M
NetNonOperatingInterestIncomeExpense-100000.0154000.0-1 M-4 M-27 M-23 M-57 M-63 M-37 M14 M
NonRecurringOperationExpense-7 M617000.0
Normalized income-88 M-143 M-169 M-29 M-363 M-564 M-436 M-380 M
Operating income-134 M-220 M-267 M-172 M-344 M-706 M-564 M-460 M-536 M-268 M
Operating income before depreciation (EBITDA)-130 M-214 M-260 M-36 M-324 M-667 M-466 M-317 M-595 M-454 M
OperatingExpense144 M221 M272 M290 M611 M1,020 M1,041 M1,055 M1,329 M1,361 M
Other income net2 M-154000.0535000.0-123 M19 M8 M-95 M-130 M65 M154 M
OtherGandA49 M75 M84 M123 M208 M285 M318 M283 M451 M482 M
OtherImpairmentOfCapitalAssets4 M3 M30 M
OtherOperatingExpenses144 M-613000.0-801000.0-735000.0-2 M-4 M-7 M-6 M-8 M-4 M
PromotionAndAdvertising15 M29 M
RentAndLandingFees4 M5 M6 M4 M8 M
Research & development expense94 M146 M188 M167 M402 M734 M722 M771 M877 M877 M
ResearchExpense94 M146 M188 M167 M402 M734 M722 M771 M877 M877 M
RestructringAndMnAIncome14000.05 M3 M-2 M
Revenue per share29000.01 M900000.0800000.0700000.0700000.0714000.02 M
SalariesAndWages-32 M3 M26 M
Selling Gen & administrative expense49 M75 M84 M123 M208 M285 M318 M283 M451 M482 M
SellingAndMarketingExpense15 M29 M
Special income/charges-14000.0-5 M-3 M2 M7 M-617000.0
Total Income available for interest expense (EBIT)-136 M-220 M-265 M-43 M-329 M-683 M-493 M-355 M-637 M-498 M
Total common shares outstanding41 M46 M55 M65 M71 M78 M79 M87 M88 M94 M
Total net income-136 M-220 M-267 M-51 M-362 M-715 M-554 M-419 M-703 M-536 M
Total ordinary shares95 M95 M95 M95 M95 M95 M95 M95 M95 M95 M
Total revenues10 M1 M5 M155 M602 M381 M456 M612 M844 M1,145 M
TotalExpenses144 M443 M272 M255 M576 M953 M978 M947 M1,189 M1,210 M
TotalRevenue10 M1 M5 M155 M301 M381 M540 M702 M933 M1,243 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University